Article List

WPRIM Management System> DCMS> Chinese Journal of Laboratory Medicine> 2022> 45> 8

Volume: 45 Issue: 8

1. Thinking and prospect of the application of flow cytometry in laboratory testing of chimeric antigen receptor T cell immunotherapy	Page:767—770
2. Opportunities and challenges for the clinical application of multi-parameter flow cytometry in the era of chimeric antigen receptor-modified T cell immunotherapy	Page:771—776
3. Chimeric antigen receptor T cell immunotherapy for refractory and relapsed acute lymphoblastic leukemia: Challenge and Countermeasures	Page:777—782
4. Reconceptualization of the value of blood markers for the diagnosis of Alzheimer disease	Page:783—789
5. Significance of multicolor flow cytometry in the detection of minimal residual disease in monitoring CD19-CAR-T cell bridging allo-HSCT treatment of B-ALL patients	Page:813—819
6. Exploration on the method of combined morphological and flow cytometry detection of chimeric antigen receptor T cells	Page:820—824
7. The level of regulatory T lymphocyte detected by flow cytometry in chimeric antigen receptor T cell immunotherapy and its clinical significance	Page:825—832
8. Immune reconstitution in patients with allogeneic hematopoietic stem cell transplantation after CAR-T immunotherapy	Page:833—839
9. The monitoring value of twelve inflammatory cytokines in chimeric antigen receptor T cell immunotherapy	Page:840—845
10. Coagulation function changes after CD19-CAR-T cells immunotherapy for B-ALL and its related factors	Page:846—851
11. To establish a method of serum detection by Raman spectroscopy for the diagnosis of gastric cancer	Page:852—858
12. Impact of serum tenascin-C level on the long-term prognosis of patients with acute ST-segment elevation myocardial infarction	Page:859—864
13. Establishment and verification validation of plasma free metanephrines measurement by chemiluminescence immunoassay	Page:865—870
14. Current application of chimeric antigen receptor T cell immunotherapy and related laboratory examinations	Page:871—874
15. Biomarkers for chimeric antigen receptor T cell therapy in B cell malignancies can assess therapeutic efficacy and toxicity	Page:875—880